Martin Pule

24PUBLICATIONS

140CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrochemical energy storage and conversion

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jul 01, 2026

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

|Apr 16, 2025

Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

|Jan 29, 2025

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.

Mathieu Ferrari, Farhaan Parekh, Paul Maciocia

|Nov 11, 2024

TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli

|Feb 21, 2024

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Mathieu Ferrari, Matteo Righi, Vania Baldan

|Sep 14, 2023

AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival.

Vedika Mehra, Giulia Agliardi, Juliana Dias Alves Pinto

Pageof 4

Frequent Collaborators

Paul Maciocia

Mathieu Ferrari

Sara Ghorashian

Persis J Amrolia

Evangelia Kokalaki

Francesco Nannini

Andrew Sewell

Simon Thomas

Claire Roddie

Gordon Weng-Kit Cheung

Frequent Collaborators

Paul Maciocia

Mathieu Ferrari

Sara Ghorashian

Persis J Amrolia